Journal of Clinical Endocrinology and Metabolism Treatment consisted of bicalutamide, goserelin , and cixutumumab for 13 weeks before prostatectomy. Here we report on an analysis of serum samples from 29 enrolled patients. Changes in IGF and glucose homeostasis pathways were compared to control ...
The Oncology Report All had responded to a 7-month induction course of goserelin , bicalutamide, or a similar agent. The study subjects were stratified by their perform...
The Oncology Report All had responded to a 7-month induction course of goserelin , bicalutamide, or a similar agent. The study subjects were stratified by their perform...
